China Shineway Pharmaceutical Group (China Shineway Pharmaceutical Group) ROCE % : 16.39% (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is China Shineway Pharmaceutical Group ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. China Shineway Pharmaceutical Group's annualized ROCE % for the quarter that ended in Dec. 2023 was 16.39%.

China Shineway Pharmaceutical Group ROCE % Historical Data

The historical data trend for China Shineway Pharmaceutical Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Shineway Pharmaceutical Group ROCE % Chart

China Shineway Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

10.74

7.12

12.05

13.85

17.93

China Shineway Pharmaceutical Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial															11.13	13.00	15.48	19.79	16.39

China Shineway Pharmaceutical Group ROCE % Calculation

China Shineway Pharmaceutical Group's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	174.083	/	( ( (1180.754 - 238.908)	+	(1340.858 - 340.847) )	/ 2 )
	=	174.083	/	( (941.846	+	1000.011)	/ 2 )
	=	174.083	/	970.9285
	=	17.93 %

China Shineway Pharmaceutical Group's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	160.088	/	( ( (1243.11 - 289.978)	+	(1340.858 - 340.847) )	/ 2 )
	=	160.088	/	( ( 953.132	+	1000.011 )	/ 2 )
	=	160.088	/	976.5715
	=	16.39 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

China Shineway Pharmaceutical Group (OTCPK:CSWYY) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

China Shineway Pharmaceutical Group ROCE % Related Terms

Thank you for viewing the detailed overview of China Shineway Pharmaceutical Group's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

China Shineway Pharmaceutical Group (China Shineway Pharmaceutical Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Shineway Pharmaceutical Group Ltd (OTCPK:CSWYY) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

02877:Hong Kong C1S:Germany

Address

Luan Cheng, Hebei Province, Shijiazhuang, CHN

Website

http://www.shineway.com.hk

China Shineway Pharmaceutical Group Ltd is an investment holding company in the People's Republic of China. Principally, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, and others of which injection generates maximum revenue to the company.

China Shineway Pharmaceutical Group (China Shineway Pharmaceutical Group) Headlines

From GuruFocus

China Shineway Pharmaceutical Group Ltd (CSWYF): A Deep Dive into its Dividend Performance

By GuruFocus Research • 09-12-2023